Aristolochic acid (AA) is an emerging contaminant in herbal medicines or crops, which has long been recognized for causing nephropathy. Recently, the linkage between AA and liver injury has become a concern; however, the current understanding of the mechanism or mode of action (MOA) is limited. In the present study, we investigated nuclear receptor-mediated MOA associated with AA-induced liver injury. Bioinformatic analysis of AA-interacting genes indicated nuclear receptor-mediated metabolizing pathways; Transcriptomic profiling of AA-exposed rats with liver injury suggested FXR-, NRF2-, and AHR- mediated pathways in the injured livers of the rats. Mechanistic investigation using HepG2 cells indicated AAI-induced hepatic lipid accumulation by elevating TG through inhibition of the FXR. In addition, AAI-induced hepatocellular damage by activating the AHR pathway, which further generated ROS and activated the NRF2 pathway. Together, these results provided new clues for researchers who are interested in chemical-induced liver injury.